Budget impact analysis of chronic kidney disease mass screening test in Japan. - Wikidata - wikimedia - TriplyDB

Budget impact analysis of chronic kidney disease mass screening test in Japan.

Budget impact analysis of chronic kidney disease mass screening test in Japan.

http://www.wikidata.org/entity/Q34737206

about

Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.Glucosuria and all-cause mortality among general screening participants.The First Report on the Frequency of Asymptomatic Proteinuria in Iranian School-aged Children.

P2860

Q38930272-967C199E-76F2-4831-9568-3495F50E389E Q50057769-D8C06FD7-EDC1-43A3-BAB7-26351066ADA7 Q52659172-E8074FE3-A118-4C84-93B7-72E4A8EBA51A

P2860

Budget impact analysis of chronic kidney disease mass screening test in Japan.

http://www.wikidata.org/entity/Q34737206

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@ast

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@en

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@nl

type

label

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@ast

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@en

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@nl

prefLabel

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@ast

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@en

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@nl

P1433

Q34737206-FDFFF98C-6DCF-44BA-AD31-8FFE00539EB3

P1476

Q34737206-BDBCC49D-035A-4FDD-9EEF-784BF842DD1D

P2093

Q34737206-0D608606-1195-474F-8AC5-98DA2BB176D0

Q34737206-21000ECB-BF8A-4EA7-8DD5-E353215B13A0

Q34737206-37E33D05-EB82-4D0F-9EEB-E9033096EC6D

Q34737206-5C99B15A-A8C6-4D30-972A-2ABCA1113112

Q34737206-6A09F875-D226-4BF5-A050-A827D26DDE24

Q34737206-7A3126F0-15BD-4ABA-94CF-92BA788E8408

Q34737206-8BC6E7FB-44AF-4404-AFEB-25BF103DBC35

Q34737206-9D419BD1-756A-44D0-B919-14DD860DABAD

Q34737206-A6326E9E-E669-475F-9877-99A9B9298DD2

Q34737206-B81A1577-63E0-4EFF-BA1C-2ADDB71671A8

P2860

Q34737206-0AD28DFF-5D2A-4D44-BF42-A9F7AA156767

Q34737206-0D8C9D54-EF69-4553-B725-B6ABC5C1F8BD

Q34737206-10FB0AC7-E04D-47DB-8B58-8FA977904E04

Q34737206-20F763F7-4CB5-4AB8-AF66-743767DBDB1D

Q34737206-35107FD5-939C-4321-B802-3A07484BCF21

Q34737206-46100779-D934-4ED3-86E9-210F2E950F3B

Q34737206-51100AD4-1CF6-4ED1-906D-513DE8DC2084

Q34737206-6B1A09B9-D411-4E6E-BE76-CE3F401B7EAB

Q34737206-6C359F01-0BB9-4DED-8148-EEF170FAE6C6

Q34737206-773E469E-1E9B-47C4-A1D0-C88B910C96A7

P2888

Q34737206-45426BB2-9A0F-4E3A-96FC-4D2D706BADBC

P304

Q34737206-AB69482A-AEF9-4C91-9134-438A93387E24

P31

Q34737206-4EC0317D-85D1-42E6-AEA2-B174368E5FAF

P356

Q34737206-FF05587E-ADB1-49CB-A364-407EC72E8E8E

P433

Q34737206-A39205FA-6EE8-48C0-A21A-77C935BF8601

P478

Q34737206-2A222502-853F-40FA-8F16-7A6FB43DEBC2

P50

Q34737206-7623552F-7208-46BB-9879-E98030D03173

P577

Q34737206-E28F356F-AB0C-4812-B2CC-B32B13DE5788

P5875

Q34737206-62758B0B-6080-4F47-A993-B53A81BC8054

P698

Q34737206-BD1D650B-6BA6-411B-8074-55FB53DB7C81

P932

Q34737206-A272D924-0709-4382-9891-090E34600C96

P356

S10157-014-0943-8

P1433

Clinical and experimental nephrology

P1476

Budget impact analysis of chronic kidney disease mass screening test in Japan.

@en

P2093

Ichiei Narita

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Tsuruya

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kimura

http://www.w3.org/2001/XMLSchema#string

Koichi Asahi

http://www.w3.org/2001/XMLSchema#string

Kunihiro Yamagata

http://www.w3.org/2001/XMLSchema#string

Kunitoshi Iseki

http://www.w3.org/2001/XMLSchema#string

Masahide Kondo

http://www.w3.org/2001/XMLSchema#string

Shouichi Fujimoto

http://www.w3.org/2001/XMLSchema#string

Shu-Ling Hoshi

http://www.w3.org/2001/XMLSchema#string

Toshiki Moriyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Chronic kidney disease: the global challenge.

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

Kidney disease screening program in Japan: history, outcome, and perspectives.

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Screening for chronic kidney disease: where does Europe go?

The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome.

Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.

Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD.

P2888

s10157-014-0943-8

P304

885-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-014-0943-8

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260154021

http://www.w3.org/2001/XMLSchema#string

P698

24515308

http://www.w3.org/2001/XMLSchema#string

P932

4271136

http://www.w3.org/2001/XMLSchema#string